RT Journal Article
SR Electronic
T1 Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.19.20234237
DO 10.1101/2020.11.19.20234237
A1 Fallerini, Chiara
A1 Daga, Sergio
A1 Mantovani, Stefania
A1 Benetti, Elisa
A1 Pujol, Aurora
A1 Picchiotti, Nicola
A1 Schluter, Agatha
A1 Planas-Serra, Laura
A1 Troya, Jesús
A1 Baldassarri, Margherita
A1 Fava, Francesca
A1 Ludovisi, Serena
A1 Castelli, Francesco
A1 Quiros-Roldan, Maria Eugenia
A1 Vaghi, Massimo
A1 Rusconi, Stefano
A1 Siano, Matteo
A1 Bandini, Maria
A1 Furini, Simone
A1 Mari, Francesca
A1 ,
A1 Renieri, Alessandra
A1 Mondelli, Mario U.
A1 Frullanti, Elisa
YR 2020
UL http://medrxiv.org/content/early/2020/11/27/2020.11.19.20234237.abstract
AB Background COVID-19 clinical presentation ranges from asymptomatic to fatal outcome. This variability is due in part to host genome specific mutations. Recently, two families in which COVID-19 segregates like an X-linked recessive monogenic disorder environmentally conditioned by SARS-CoV-2 have been reported leading to identification of loss-of-function variants in TLR7.Objective We sought to determine whether the two families represent the tip of the iceberg of a subset of COVID-19 male patients.Methods We compared male subjects with extreme phenotype selected from the Italian GEN-COVID cohort of 1178 SARS-CoV-2-infected subjects (<60y, 79 severe cases versus 77 control cases). We applied the LASSO Logistic Regression analysis, considering only rare variants on the young male subset, picking up TLR7 as the most important susceptibility gene.Results Rare TLR7 missense variants were predicted to impact on protein function in severely affected males and in none of the asymptomatic subjects. We then investigated a similar white European cohort in Spain, confirming the impact of TRL7 variants. A gene expression profile analysis in peripheral blood mononuclear cells after stimulation with TLR7 agonist demonstrated a reduction of mRNA level of TLR7, IRF7, ISG15, IFN-□ and IFN-γ in COVID-19 patients compared with unaffected controls demonstrating an impairment in type I and II INF responses.Conclusion Young males with TLR7 loss-of-function mutations and severe COVID-19 in the two reported families represent only a fraction of a broader and complex host genome situation. Specifically, missense mutations in the X-linked recessive TLR7 disorder may significantly contribute to disease susceptibility in up to 4% of severe COVID-19.Clinical Implication In this new yet complex scenario, our observations provide the basis for a personalized interferon-based therapy in patients with rare TLR7 variants.CAPSULE SUMMARY Our results in large cohorts from Italy and Spain showed that X-linked recessive TLR7 disorder may represent the cause of disease susceptibility to COVID-19 in up to 4% of severely affected young male cases.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04549831Funding StatementWe thank private donors for the support provided to A.R. (Department of Medical Biotechnologies, University of Siena) for the COVID19 host genetics research project (D.L n.18 of March 17, 2020). We also thank the COVID19 Host Genetics Initiative (https://www.covid19hg.org/). MIUR project Dipartimenti di Eccellenza 2018/2020 to the Department of Medical Biotechnologies University of Siena, Italy. Research on the Spanish cohort received funding from the European Unions Horizon 2020 research and innovation programme under grant agreement No 824110 EASI-Genomics, to AP.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study (GEN-COVID) was consistent with Institutional guidelines and approved by the University Hospital (Azienda Ospedaliero-Universitaria Senese) Ethical Review Board, Siena, Italy (Prot n. 16929, dated March 16, 2020). A Spanish cohort, composed of 122 COVID-19 patients, was used to expand the cohort to another representative European population highly impacted by COVID-19. The Spanish Covid HGE cohort is under IRB approval PR127/20 from Bellvitge University Hospital, Barcelona, Spain.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data and samples referenced here are housed in the GEN-COVID Patient Registry and the GEN-COVID Biobank and are available for consultation. For further information, you may contact the corresponding author, Prof. Alessandra Renieri (e-mail: alessandra.renieri{at}unisi.it).http://www.nig.cineca.ithttps://www.covid19hg.org/http://nigdb.cineca.itAlaAlanine amino acidAspAsparagine amino acidCADDCombined Annotation Dependent DepletionCOVID-19COronaVIrus Disease 19HisHistidine amino acidHPRT1hypoxanthine phosphoribosyltransferase 1INFsInterferonsIFN-αInterferon AlphaIFN-β1Interferon Beta1IFN-γInterferon GammaIL-1Interleukin 1IL-6Interleukin 6IleIsoleucine amino acidIRF7Interferon Regulatory Factor 7ISG15Interferon-Stimulated Gene 15LASSOLeast Absolute Shrinkage and Selection OperatorLBPLipoPolySaccharide(LPS)Binding ProteinNIGNetwork of Italian GenomePBMCsPeripheral Blood Mononuclear CellsProProline amino acidRNARiboNucleic AcidSerSerine amino acidSARS-CoV-2Severe Acute Respiratory Syndrome caused by CoronaVirusThrThreonine amino acidTLRsToll-like ReceptorsTLR4Toll-like Receptor 4TLR7Toll-like Receptor 7TNF-αTumor Necrosis Factor αTyrTyrosine amino acidValValine amino acidWESWhole Exome Sequencing